Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade.
Zhao L, Pang Y, Zhou Y, Chen J, Fu H, Guo W, Xu W, Xue X, Su G, Sun L, Wu H, Zhang J, Wang Z, Lin Q, Chen X, Chen H.
Zhao L, et al. Among authors: su g.
Signal Transduct Target Ther. 2024 Jun 3;9(1):142. doi: 10.1038/s41392-024-01853-w.
Signal Transduct Target Ther. 2024.
PMID: 38825657
Free PMC article.